← Patent-cliff monitor small molecule FIRDAPSE AMIFAMPRIDINE PHOSPHATE
Loss of exclusivity February 2037 latest FDA-listed patent expiry
Company Catalyst
Drug detail Brand name FIRDAPSE Active ingredient AMIFAMPRIDINE PHOSPHATE Strength EQ 10MG BASE Dosage form TABLET Route ORAL Modality Small molecule FDA approval November 2018 Marketing status RX
Listed patents Patent Expires Type 10626088 February 2037 product 10793893 May 2034 use U-2956 11274332 June 2032 use U-2956 11274331 June 2032 use U-2956 11268128 June 2032 use U-2956 11060128 June 2032 use U-2956
Regulatory exclusivity Code Expires ODE-553 September 2029
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.